PAVmed Inc.
PAVM- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001624326
No open-market purchases or sales by PAVmed Inc. insiders were filed in the last 90 days; 19 institutions reported holding it in 13F filings for Q2 2026, worth $5.56M in total; no superinvestor holds it.
13F holders, Q1 2024
Institutional positions in PAVmed Inc. as of Mar 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 24
- −2 vs. Q4 2023
- Shares held
- 952.8K
- +199.1K (+26.4%) vs. Q4 2023
- Total value
- $2.03M
- −$1.07M (−34.5%) vs. Q4 2023
- New holders
- 3
- 4 more added
- Sold out
- 5
- 11 more reduced
Compare with Q4 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting PAVM on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 19 | $5.56M |
| Q1 2026 | 21 | $5.26M |
| Q4 2025 | 32 | $468.8K |
| Q3 2025 | 36 | $677.4K |
| Q2 2025 | 32 | $755.8K |
| Q1 2025 | 31 | $873.5K |
| Q4 2024 | 26 | $653.8K |
| Q3 2024 | 22 | $1.38M |
| Q2 2024 | 26 | $931.9K |
| Q1 2024 | 24 | $2.03M |
| Q4 2023 | 26 | $3.10M |
| Q3 2023 | 65 | $3.67M |
| Q2 2023 | 58 | $3.78M |
| Q1 2023 | 61 | $3.76M |
| Q4 2022 | 64 | $4.62M |
| Q3 2022 | 73 | $10.9M |
| Q2 2022 | 76 | $11.5M |
| Q1 2022 | 96 | $27.0M |
| Q4 2021 | 108 | $65.5M |
| Q3 2021 | 109 | $198.9M |
| Q2 2021 | 101 | $134.7M |
| Q1 2021 | 92 | $80.8M |
Institutions, Q1 2024
Shares, value and share of portfolio for each institution holding PAVmed Inc.; share changes are against Q4 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| First Manhattan Co | 425,000 | $909.5K | 0.00% | +225,000+112.5% | Added |
| Vanguard Group Inc | 300,541 | $643.2K | 0.00% | −2,065−0.7% | Reduced |
| BlackRock Inc. | 74,912 | $160.3K | 0.00% | −100.0% | Reduced |
| Geode Capital Management, LLC | 63,360 | $135.6K | 0.00% | +8,282+15.0% | Added |
| State Street Corp | 20,981 | $44.9K | 0.00% | 00.0% | Unchanged |
| Valeo Financial Advisors, LLC | 21,129 | $39.1K | 0.00% | 00.0% | Unchanged |
| Northern Trust Corp | 11,752 | $25.1K | 0.00% | −1,205−9.3% | Reduced |
| XML Financial, LLC | 10,067 | $21.5K | 0.00% | −267−2.6% | Reduced |
| Wells Fargo & Company | 7,144 | $15.3K | 0.00% | −4,274−37.4% | Reduced |
| Morgan Stanley | 5,129 | $11.0K | 0.00% | +2,545+98.5% | Added |
| CWM, LLC | 4,672 | $10.0K | 0.00% | 00.0% | Unchanged |
| Clear Street Markets LLC | 3,612 | $8.00K | 0.00% | +3,612 | New |
| Tower Research Capital LLC (TRC) | 2,457 | $5.26K | 0.00% | −1,315−34.9% | Reduced |
| CIBC Private Wealth Group, LLC | 836 | $1.71K | 0.00% | +836 | New |
| Allworth Financial LP | 420 | $899 | 0.00% | −604−59.0% | Reduced |
| Newbridge Financial Services Group, Inc. | 134 | $287 | 0.00% | +134 | New |
| Advisor Group Holdings, Inc. | 128 | $273 | 0.00% | −54−29.7% | Reduced |
| M&R Capital Management Inc | 67 | $143 | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 36 | $78 | 0.00% | +6+20.0% | Added |
| Bank of America Corp | 7 | $15 | 0.00% | −8−53.3% | Reduced |
| Thompson Investment Management, Inc. | 4 | $9 | 0.00% | 00.0% | Unchanged |
| Steward Partners Investment Advisory, LLC | 1 | $2 | 0.00% | 00.0% | Unchanged |
| Simplex Trading, LLC | 400 | $0 | 0.00% | −591−59.6% | Reduced |
| Royal Bank of Canada | 11 | $0 | 0.00% | −27−71.1% | Reduced |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −22,561−100.0% | Sold out |
| UBS Group AG | 0 | $0 | 0.00% | −6,017−100.0% | Sold out |
| Glassman Wealth Services | 0 | $0 | 0.00% | −2,319−100.0% | Sold out |
| Rockbridge Investment Management, LCC | 0 | $0 | 0.00% | −27−100.0% | Sold out |
| FMR LLC | 0 | $0 | 0.00% | −1−100.0% | Sold out |